ISPOR Europe 2025 brought together global HTA bodies, payers, industry leaders and patient organisat...
Objectives: To analyse how the mandatory EU Joint Clinical Assessment (JCA) could in...
Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.